世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ライム病診断装置の世界市場成長率 2024-2030


Global Lyme Disease Diagnostic Devices Market Growth 2024-2030

LPI(LPインフォメーション)の最新調査によると、世界のライム病診断機器市場規模は2023年に100万米ドルとなった。川下市場での需要拡大に伴い、ライム病診断装置は2030年までに100万米ドルの再調整規模になると... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2024年6月21日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

LPI(LPインフォメーション)の最新調査によると、世界のライム病診断機器市場規模は2023年に100万米ドルとなった。川下市場での需要拡大に伴い、ライム病診断装置は2030年までに100万米ドルの再調整規模になると予測され、レビュー期間中のCAGRは%である。
この調査レポートは、世界のライム病診断装置市場の成長の可能性を明らかにしています。ライム病診断装置は、今後の市場でも安定した成長が期待される。しかし、ライム病診断装置の普及には、製品の差別化、コストの削減、サプライチェーンの最適化が引き続き重要である。市場関係者は、ライム病診断機器市場がもたらす莫大なビジネスチャンスを活用するために、研究開発への投資、戦略的パートナーシップの構築、消費者の嗜好の変化に合わせた製品提供を行う必要がある。
ライム病診断装置は、スピロヘータBorrelia burgdorferiによって引き起こされ、媒介動物Ixodes scapularによって感染する病気を検出するために使用される、
当社の調査によると、医療機器の世界市場は2023年に6,030億米ドルと推定され、今後6年間は年平均成長率5%で成長する。世界の医療支出は世界GDPの10%を占め、高齢化による健康ニーズの増加、慢性疾患や感染症の流行、新興市場の拡大により、近年増加の一途をたどっています。医療機器市場は、ヘルスケア産業において重要な役割を果たしている。同市場は、世界的な高度医療サービスに対する需要の増加、医療技術の進歩、高齢者人口の増加、医療費の増加、病気の早期診断と治療に対する意識の高まりなど、いくつかの要因によって牽引されている。
主な特徴
ライム病診断機器市場に関する本レポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。
市場規模と成長:この調査レポートは、ライム病診断装置市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分(血清検査、尿中抗原検査など)、地域別内訳を含む場合があります。
市場促進要因と課題:ライム病診断薬市場の成長を促進する要因(政府規制、環境問題、技術の進歩、消費者の嗜好の変化など)を特定・分析することができます。また、インフラストラクチャーの制約、射程距離への不安、高額な初期費用など、業界が直面する課題も浮き彫りにすることができる。
競合情勢:本調査レポートは、ライム病診断機器市場における競合状況の分析を提供します。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれる。また、新興プレーヤーとその潜在的な市場への影響もハイライトすることができる。
技術開発:調査レポートは、ライム病診断機器業界における最新の技術開発について掘り下げることができます。これには、ライム病診断薬技術の進歩、ライム病診断薬の新規参入、ライム病診断薬の新規投資、ライム病診断薬の将来を形作るその他の技術革新が含まれる。
川下企業の好み:本レポートは、ライム病診断薬市場における顧客の購買行動と採用動向を明らかにすることができる。顧客の購買決定、ライム病診断装置製品の嗜好に影響を与える要因も含まれる。
政府の政策とインセンティブ調査レポートは、ライム病診断装置市場に与える政府の政策とインセンティブの影響を分析する。これには、ライム病診断薬市場の促進を目的とした規制の枠組み、補助金、税制優遇措置などの評価が含まれる。また、市場成長促進におけるこれらの政策の有効性も評価する。
環境への影響と持続可能性調査レポートでは、ライム病診断機器市場の環境への影響と持続可能性の側面を評価します。
市場予測と将来展望:調査レポートは、実施した分析に基づき、ライム病診断装置産業の市場予測と展望を提供します。これには、市場規模、成長率、地域別動向、技術進歩や政策展開に関する予測などが含まれる。
提言と機会本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられています。市場関係者が新たなトレンドを活用し、課題を克服し、ライム病診断機器市場の成長と発展に貢献するための潜在的な機会を強調しています。
市場の細分化
ライム病診断機器市場はタイプ別、用途別に分類される。2019年から2030年までの期間について、セグメント間の成長により、タイプ別、用途別の消費額の正確な計算と予測を数量と金額で提供します。
タイプ別セグメント
血清学的検査
尿中抗原検査
リンパ球形質転換検査
免疫蛍光染色
核酸検査
用途別セグメンテーション
病院
公立/私立研究所
医師事務所
本レポートではまた、市場を地域別に分けています:
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
アボット・ラボラトリーズ
T2バイオシステムズ
バイオ・ラッド・ラボラトリーズ
アレール社
ロシュ・ダイアグノスティックス
コバンス社
イムネティクス社
グラクソ・スミスクライン plc(グラクソ・スミスクライン・ファーマシューティカルズ・リミテッド)
オックスフォード・イムノテック・グローバルPLC(ボルダー・ダイアグノスティックス)
サーモフィッシャーサイエンティフィック(アフィメトリクス)
シーメンスAG
バクスター・インターナショナル
フレゼニウス・メディカル・ケア社
本レポートで扱う主な質問
世界のライム病診断機器市場の10年間の見通しは?
世界および地域別で、ライム病診断機器市場の成長を促進する要因は何か?
市場別、地域別に最も急成長する技術は何か?
ライム病診断薬の市場機会は最終市場規模によってどのように異なるのか?
ライム病診断薬のタイプ別、用途別内訳は?


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lyme Disease Diagnostic Devices Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Lyme Disease Diagnostic Devices by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Lyme Disease Diagnostic Devices by Country/Region, 2019, 2023 & 2030
2.2 Lyme Disease Diagnostic Devices Segment by Type
2.2.1 Serological Test
2.2.2 Urine Antigen Tests
2.2.3 Lymphocytic Transformation Test
2.2.4 Immunofluorescent Staining
2.2.5 Nucleic Acid Test
2.3 Lyme Disease Diagnostic Devices Sales by Type
2.3.1 Global Lyme Disease Diagnostic Devices Sales Market Share by Type (2019-2024)
2.3.2 Global Lyme Disease Diagnostic Devices Revenue and Market Share by Type (2019-2024)
2.3.3 Global Lyme Disease Diagnostic Devices Sale Price by Type (2019-2024)
2.4 Lyme Disease Diagnostic Devices Segment by Application
2.4.1 Hospitals
2.4.2 Public/Private Laboratories
2.4.3 Physician’s Office
2.5 Lyme Disease Diagnostic Devices Sales by Application
2.5.1 Global Lyme Disease Diagnostic Devices Sale Market Share by Application (2019-2024)
2.5.2 Global Lyme Disease Diagnostic Devices Revenue and Market Share by Application (2019-2024)
2.5.3 Global Lyme Disease Diagnostic Devices Sale Price by Application (2019-2024)
3 Global Lyme Disease Diagnostic Devices by Company
3.1 Global Lyme Disease Diagnostic Devices Breakdown Data by Company
3.1.1 Global Lyme Disease Diagnostic Devices Annual Sales by Company (2019-2024)
3.1.2 Global Lyme Disease Diagnostic Devices Sales Market Share by Company (2019-2024)
3.2 Global Lyme Disease Diagnostic Devices Annual Revenue by Company (2019-2024)
3.2.1 Global Lyme Disease Diagnostic Devices Revenue by Company (2019-2024)
3.2.2 Global Lyme Disease Diagnostic Devices Revenue Market Share by Company (2019-2024)
3.3 Global Lyme Disease Diagnostic Devices Sale Price by Company
3.4 Key Manufacturers Lyme Disease Diagnostic Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lyme Disease Diagnostic Devices Product Location Distribution
3.4.2 Players Lyme Disease Diagnostic Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Lyme Disease Diagnostic Devices by Geographic Region
4.1 World Historic Lyme Disease Diagnostic Devices Market Size by Geographic Region (2019-2024)
4.1.1 Global Lyme Disease Diagnostic Devices Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Lyme Disease Diagnostic Devices Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Lyme Disease Diagnostic Devices Market Size by Country/Region (2019-2024)
4.2.1 Global Lyme Disease Diagnostic Devices Annual Sales by Country/Region (2019-2024)
4.2.2 Global Lyme Disease Diagnostic Devices Annual Revenue by Country/Region (2019-2024)
4.3 Americas Lyme Disease Diagnostic Devices Sales Growth
4.4 APAC Lyme Disease Diagnostic Devices Sales Growth
4.5 Europe Lyme Disease Diagnostic Devices Sales Growth
4.6 Middle East & Africa Lyme Disease Diagnostic Devices Sales Growth
5 Americas
5.1 Americas Lyme Disease Diagnostic Devices Sales by Country
5.1.1 Americas Lyme Disease Diagnostic Devices Sales by Country (2019-2024)
5.1.2 Americas Lyme Disease Diagnostic Devices Revenue by Country (2019-2024)
5.2 Americas Lyme Disease Diagnostic Devices Sales by Type
5.3 Americas Lyme Disease Diagnostic Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lyme Disease Diagnostic Devices Sales by Region
6.1.1 APAC Lyme Disease Diagnostic Devices Sales by Region (2019-2024)
6.1.2 APAC Lyme Disease Diagnostic Devices Revenue by Region (2019-2024)
6.2 APAC Lyme Disease Diagnostic Devices Sales by Type
6.3 APAC Lyme Disease Diagnostic Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Lyme Disease Diagnostic Devices by Country
7.1.1 Europe Lyme Disease Diagnostic Devices Sales by Country (2019-2024)
7.1.2 Europe Lyme Disease Diagnostic Devices Revenue by Country (2019-2024)
7.2 Europe Lyme Disease Diagnostic Devices Sales by Type
7.3 Europe Lyme Disease Diagnostic Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lyme Disease Diagnostic Devices by Country
8.1.1 Middle East & Africa Lyme Disease Diagnostic Devices Sales by Country (2019-2024)
8.1.2 Middle East & Africa Lyme Disease Diagnostic Devices Revenue by Country (2019-2024)
8.2 Middle East & Africa Lyme Disease Diagnostic Devices Sales by Type
8.3 Middle East & Africa Lyme Disease Diagnostic Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lyme Disease Diagnostic Devices
10.3 Manufacturing Process Analysis of Lyme Disease Diagnostic Devices
10.4 Industry Chain Structure of Lyme Disease Diagnostic Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lyme Disease Diagnostic Devices Distributors
11.3 Lyme Disease Diagnostic Devices Customer
12 World Forecast Review for Lyme Disease Diagnostic Devices by Geographic Region
12.1 Global Lyme Disease Diagnostic Devices Market Size Forecast by Region
12.1.1 Global Lyme Disease Diagnostic Devices Forecast by Region (2025-2030)
12.1.2 Global Lyme Disease Diagnostic Devices Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lyme Disease Diagnostic Devices Forecast by Type
12.7 Global Lyme Disease Diagnostic Devices Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.1.3 Abbott Laboratories Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 T2 Biosystems, Inc.
13.2.1 T2 Biosystems, Inc. Company Information
13.2.2 T2 Biosystems, Inc. Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.2.3 T2 Biosystems, Inc. Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 T2 Biosystems, Inc. Main Business Overview
13.2.5 T2 Biosystems, Inc. Latest Developments
13.3 Bio-Rad Laboratories
13.3.1 Bio-Rad Laboratories Company Information
13.3.2 Bio-Rad Laboratories Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.3.3 Bio-Rad Laboratories Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bio-Rad Laboratories Main Business Overview
13.3.5 Bio-Rad Laboratories Latest Developments
13.4 Alere Inc.
13.4.1 Alere Inc. Company Information
13.4.2 Alere Inc. Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.4.3 Alere Inc. Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Alere Inc. Main Business Overview
13.4.5 Alere Inc. Latest Developments
13.5 Roche Diagnostics
13.5.1 Roche Diagnostics Company Information
13.5.2 Roche Diagnostics Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.5.3 Roche Diagnostics Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Roche Diagnostics Main Business Overview
13.5.5 Roche Diagnostics Latest Developments
13.6 Covance Inc.
13.6.1 Covance Inc. Company Information
13.6.2 Covance Inc. Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.6.3 Covance Inc. Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Covance Inc. Main Business Overview
13.6.5 Covance Inc. Latest Developments
13.7 Immunetics, Inc.
13.7.1 Immunetics, Inc. Company Information
13.7.2 Immunetics, Inc. Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.7.3 Immunetics, Inc. Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Immunetics, Inc. Main Business Overview
13.7.5 Immunetics, Inc. Latest Developments
13.8 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd)
13.8.1 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Company Information
13.8.2 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.8.3 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Main Business Overview
13.8.5 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Latest Developments
13.9 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.)
13.9.1 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Company Information
13.9.2 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.9.3 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Main Business Overview
13.9.5 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Latest Developments
13.10 Thermo Fisher Scientific(Affymetrix)
13.10.1 Thermo Fisher Scientific(Affymetrix) Company Information
13.10.2 Thermo Fisher Scientific(Affymetrix) Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.10.3 Thermo Fisher Scientific(Affymetrix) Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Thermo Fisher Scientific(Affymetrix) Main Business Overview
13.10.5 Thermo Fisher Scientific(Affymetrix) Latest Developments
13.11 Siemens AG
13.11.1 Siemens AG Company Information
13.11.2 Siemens AG Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.11.3 Siemens AG Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Siemens AG Main Business Overview
13.11.5 Siemens AG Latest Developments
13.12 Baxter International Inc.
13.12.1 Baxter International Inc. Company Information
13.12.2 Baxter International Inc. Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.12.3 Baxter International Inc. Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Baxter International Inc. Main Business Overview
13.12.5 Baxter International Inc. Latest Developments
13.13 Fresenius Medical Care AG & Co.
13.13.1 Fresenius Medical Care AG & Co. Company Information
13.13.2 Fresenius Medical Care AG & Co. Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.13.3 Fresenius Medical Care AG & Co. Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Fresenius Medical Care AG & Co. Main Business Overview
13.13.5 Fresenius Medical Care AG & Co. Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

According to our LPI (LP Information) latest study, the global Lyme Disease Diagnostic Devices market size was valued at US$ million in 2023. With growing demand in downstream market, the Lyme Disease Diagnostic Devices is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Lyme Disease Diagnostic Devices market. Lyme Disease Diagnostic Devices are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Lyme Disease Diagnostic Devices. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Lyme Disease Diagnostic Devices market.
Lyme disease diagnostic devices are used to detect disease which is caused by the spirochete Borrelia burgdorferi and transmitted by vector Ixodes scapular,
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Lyme Disease Diagnostic Devices market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Lyme Disease Diagnostic Devices market. It may include historical data, market segmentation by Type (e.g., Serological Test, Urine Antigen Tests), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Lyme Disease Diagnostic Devices market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Lyme Disease Diagnostic Devices market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Lyme Disease Diagnostic Devices industry. This include advancements in Lyme Disease Diagnostic Devices technology, Lyme Disease Diagnostic Devices new entrants, Lyme Disease Diagnostic Devices new investment, and other innovations that are shaping the future of Lyme Disease Diagnostic Devices.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Lyme Disease Diagnostic Devices market. It includes factors influencing customer ' purchasing decisions, preferences for Lyme Disease Diagnostic Devices product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Lyme Disease Diagnostic Devices market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Lyme Disease Diagnostic Devices market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Lyme Disease Diagnostic Devices market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Lyme Disease Diagnostic Devices industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Lyme Disease Diagnostic Devices market.
Market Segmentation:
Lyme Disease Diagnostic Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Serological Test
Urine Antigen Tests
Lymphocytic Transformation Test
Immunofluorescent Staining
Nucleic Acid Test
Segmentation by application
Hospitals
Public/Private Laboratories
Physician’s Office
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
T2 Biosystems, Inc.
Bio-Rad Laboratories
Alere Inc.
Roche Diagnostics
Covance Inc.
Immunetics, Inc.
GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd)
Oxford Immunotec Global PLC(Boulder Diagnostics Inc.)
Thermo Fisher Scientific(Affymetrix)
Siemens AG
Baxter International Inc.
Fresenius Medical Care AG & Co.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Lyme Disease Diagnostic Devices market?
What factors are driving Lyme Disease Diagnostic Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lyme Disease Diagnostic Devices market opportunities vary by end market size?
How does Lyme Disease Diagnostic Devices break out type, application?



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lyme Disease Diagnostic Devices Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Lyme Disease Diagnostic Devices by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Lyme Disease Diagnostic Devices by Country/Region, 2019, 2023 & 2030
2.2 Lyme Disease Diagnostic Devices Segment by Type
2.2.1 Serological Test
2.2.2 Urine Antigen Tests
2.2.3 Lymphocytic Transformation Test
2.2.4 Immunofluorescent Staining
2.2.5 Nucleic Acid Test
2.3 Lyme Disease Diagnostic Devices Sales by Type
2.3.1 Global Lyme Disease Diagnostic Devices Sales Market Share by Type (2019-2024)
2.3.2 Global Lyme Disease Diagnostic Devices Revenue and Market Share by Type (2019-2024)
2.3.3 Global Lyme Disease Diagnostic Devices Sale Price by Type (2019-2024)
2.4 Lyme Disease Diagnostic Devices Segment by Application
2.4.1 Hospitals
2.4.2 Public/Private Laboratories
2.4.3 Physician’s Office
2.5 Lyme Disease Diagnostic Devices Sales by Application
2.5.1 Global Lyme Disease Diagnostic Devices Sale Market Share by Application (2019-2024)
2.5.2 Global Lyme Disease Diagnostic Devices Revenue and Market Share by Application (2019-2024)
2.5.3 Global Lyme Disease Diagnostic Devices Sale Price by Application (2019-2024)
3 Global Lyme Disease Diagnostic Devices by Company
3.1 Global Lyme Disease Diagnostic Devices Breakdown Data by Company
3.1.1 Global Lyme Disease Diagnostic Devices Annual Sales by Company (2019-2024)
3.1.2 Global Lyme Disease Diagnostic Devices Sales Market Share by Company (2019-2024)
3.2 Global Lyme Disease Diagnostic Devices Annual Revenue by Company (2019-2024)
3.2.1 Global Lyme Disease Diagnostic Devices Revenue by Company (2019-2024)
3.2.2 Global Lyme Disease Diagnostic Devices Revenue Market Share by Company (2019-2024)
3.3 Global Lyme Disease Diagnostic Devices Sale Price by Company
3.4 Key Manufacturers Lyme Disease Diagnostic Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lyme Disease Diagnostic Devices Product Location Distribution
3.4.2 Players Lyme Disease Diagnostic Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Lyme Disease Diagnostic Devices by Geographic Region
4.1 World Historic Lyme Disease Diagnostic Devices Market Size by Geographic Region (2019-2024)
4.1.1 Global Lyme Disease Diagnostic Devices Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Lyme Disease Diagnostic Devices Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Lyme Disease Diagnostic Devices Market Size by Country/Region (2019-2024)
4.2.1 Global Lyme Disease Diagnostic Devices Annual Sales by Country/Region (2019-2024)
4.2.2 Global Lyme Disease Diagnostic Devices Annual Revenue by Country/Region (2019-2024)
4.3 Americas Lyme Disease Diagnostic Devices Sales Growth
4.4 APAC Lyme Disease Diagnostic Devices Sales Growth
4.5 Europe Lyme Disease Diagnostic Devices Sales Growth
4.6 Middle East & Africa Lyme Disease Diagnostic Devices Sales Growth
5 Americas
5.1 Americas Lyme Disease Diagnostic Devices Sales by Country
5.1.1 Americas Lyme Disease Diagnostic Devices Sales by Country (2019-2024)
5.1.2 Americas Lyme Disease Diagnostic Devices Revenue by Country (2019-2024)
5.2 Americas Lyme Disease Diagnostic Devices Sales by Type
5.3 Americas Lyme Disease Diagnostic Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lyme Disease Diagnostic Devices Sales by Region
6.1.1 APAC Lyme Disease Diagnostic Devices Sales by Region (2019-2024)
6.1.2 APAC Lyme Disease Diagnostic Devices Revenue by Region (2019-2024)
6.2 APAC Lyme Disease Diagnostic Devices Sales by Type
6.3 APAC Lyme Disease Diagnostic Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Lyme Disease Diagnostic Devices by Country
7.1.1 Europe Lyme Disease Diagnostic Devices Sales by Country (2019-2024)
7.1.2 Europe Lyme Disease Diagnostic Devices Revenue by Country (2019-2024)
7.2 Europe Lyme Disease Diagnostic Devices Sales by Type
7.3 Europe Lyme Disease Diagnostic Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lyme Disease Diagnostic Devices by Country
8.1.1 Middle East & Africa Lyme Disease Diagnostic Devices Sales by Country (2019-2024)
8.1.2 Middle East & Africa Lyme Disease Diagnostic Devices Revenue by Country (2019-2024)
8.2 Middle East & Africa Lyme Disease Diagnostic Devices Sales by Type
8.3 Middle East & Africa Lyme Disease Diagnostic Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lyme Disease Diagnostic Devices
10.3 Manufacturing Process Analysis of Lyme Disease Diagnostic Devices
10.4 Industry Chain Structure of Lyme Disease Diagnostic Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lyme Disease Diagnostic Devices Distributors
11.3 Lyme Disease Diagnostic Devices Customer
12 World Forecast Review for Lyme Disease Diagnostic Devices by Geographic Region
12.1 Global Lyme Disease Diagnostic Devices Market Size Forecast by Region
12.1.1 Global Lyme Disease Diagnostic Devices Forecast by Region (2025-2030)
12.1.2 Global Lyme Disease Diagnostic Devices Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lyme Disease Diagnostic Devices Forecast by Type
12.7 Global Lyme Disease Diagnostic Devices Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.1.3 Abbott Laboratories Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 T2 Biosystems, Inc.
13.2.1 T2 Biosystems, Inc. Company Information
13.2.2 T2 Biosystems, Inc. Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.2.3 T2 Biosystems, Inc. Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 T2 Biosystems, Inc. Main Business Overview
13.2.5 T2 Biosystems, Inc. Latest Developments
13.3 Bio-Rad Laboratories
13.3.1 Bio-Rad Laboratories Company Information
13.3.2 Bio-Rad Laboratories Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.3.3 Bio-Rad Laboratories Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bio-Rad Laboratories Main Business Overview
13.3.5 Bio-Rad Laboratories Latest Developments
13.4 Alere Inc.
13.4.1 Alere Inc. Company Information
13.4.2 Alere Inc. Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.4.3 Alere Inc. Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Alere Inc. Main Business Overview
13.4.5 Alere Inc. Latest Developments
13.5 Roche Diagnostics
13.5.1 Roche Diagnostics Company Information
13.5.2 Roche Diagnostics Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.5.3 Roche Diagnostics Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Roche Diagnostics Main Business Overview
13.5.5 Roche Diagnostics Latest Developments
13.6 Covance Inc.
13.6.1 Covance Inc. Company Information
13.6.2 Covance Inc. Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.6.3 Covance Inc. Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Covance Inc. Main Business Overview
13.6.5 Covance Inc. Latest Developments
13.7 Immunetics, Inc.
13.7.1 Immunetics, Inc. Company Information
13.7.2 Immunetics, Inc. Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.7.3 Immunetics, Inc. Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Immunetics, Inc. Main Business Overview
13.7.5 Immunetics, Inc. Latest Developments
13.8 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd)
13.8.1 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Company Information
13.8.2 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.8.3 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Main Business Overview
13.8.5 GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) Latest Developments
13.9 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.)
13.9.1 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Company Information
13.9.2 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.9.3 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Main Business Overview
13.9.5 Oxford Immunotec Global PLC(Boulder Diagnostics Inc.) Latest Developments
13.10 Thermo Fisher Scientific(Affymetrix)
13.10.1 Thermo Fisher Scientific(Affymetrix) Company Information
13.10.2 Thermo Fisher Scientific(Affymetrix) Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.10.3 Thermo Fisher Scientific(Affymetrix) Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Thermo Fisher Scientific(Affymetrix) Main Business Overview
13.10.5 Thermo Fisher Scientific(Affymetrix) Latest Developments
13.11 Siemens AG
13.11.1 Siemens AG Company Information
13.11.2 Siemens AG Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.11.3 Siemens AG Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Siemens AG Main Business Overview
13.11.5 Siemens AG Latest Developments
13.12 Baxter International Inc.
13.12.1 Baxter International Inc. Company Information
13.12.2 Baxter International Inc. Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.12.3 Baxter International Inc. Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Baxter International Inc. Main Business Overview
13.12.5 Baxter International Inc. Latest Developments
13.13 Fresenius Medical Care AG & Co.
13.13.1 Fresenius Medical Care AG & Co. Company Information
13.13.2 Fresenius Medical Care AG & Co. Lyme Disease Diagnostic Devices Product Portfolios and Specifications
13.13.3 Fresenius Medical Care AG & Co. Lyme Disease Diagnostic Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Fresenius Medical Care AG & Co. Main Business Overview
13.13.5 Fresenius Medical Care AG & Co. Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

本レポートと同じKEY WORD(diagnostic)の最新刊レポート


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/19 10:26

155.94 円

162.31 円

199.02 円

ページTOPに戻る